Dyax

Jerini AG

Jerini AG develops peptide-based drugs for patients with rare diseases like hereditary angioedema and collaborates with pharmaceutical companies to treat cancer and inflammatory conditions.

PHVS

This company develops oral therapies to treat and prevent hereditary angioedema attacks for patients with rare diseases.

Diagonal Therapeutics

This biotechnology company develops agonist antibody treatments for patients with rare genetic diseases like hereditary haemorrhagic telangiectasia and pulmonary arterial hypertension.

Arxx Therapeutics

This biotechnology firm develops monoclonal antibody therapies for patients suffering from chronic inflammatory and fibrotic diseases.

Pharvaris

Pharvaris develops oral bradykinin B2 receptor antagonists to treat patients with hereditary angioedema and other bradykinin-mediated diseases.

FF Pharmaceuticals

This company develops monoclonal antibody therapeutics to treat inflammatory and autoimmune diseases for patients with conditions such as Crohn's disease.

Promedior

This biotechnology company develops drug therapies to treat rare fibrotic diseases for patients with conditions such as idiopathic pulmonary fibrosis and myelofibrosis.

Kinaset Therapeutics

This biopharmaceutical company develops inhaled anti-inflammatory therapies to treat patients with severe asthma and other respiratory diseases.